Company Genocea Biosciences, Inc.

Equities

GNCAQ

US3724274010

Biotechnology & Medical Research

Market Closed - OTC Markets 11:27:28 2024-03-19 am EDT 5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for Genocea Biosciences, Inc. 0.00% 0.00%

Business Summary

Genocea Biosciences, Inc. is a biopharmaceutical company. The Company is engaged in discovering and developing cancer immunotherapies using its proprietary ATLAS platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by next-generation sequencing of that patient's tumor. ATLAS zeroes in on both antigens that activate anti-tumor T cell responses and inhibitory antigens, or Inhibigens, that drive pro-tumor immune responses. Its GEN-009 is an investigational neoantigen vaccine delivering adjuvanted synthetic long peptides from ATLAS-identified neoantigens. The Company has a license agreement with Harvard College (Harvard), granting the Company a sublicensable license to one patent family, to develop, make, use, market licensed products, and perform licensed services related to the ATLAS discovery platform.

Number of employees: 74

Sales per Business

USD in Million2020Weight2021Weight Delta
Cancer Immunotherapies
100.0 %
1 100.0 % 2 100.0 % +20.75%

Sales per region

USD in Million2020Weight2021Weight Delta
United States
100.0 %
1 100.0 % 2 100.0 % +20.75%

Managers

Managers TitleAgeSince
Chief Tech/Sci/R&D Officer 52 07-02-28
Corporate Officer/Principal - 18-12-09

Members of the board

Members of the board TitleAgeSince
Chairman 73 14-09-10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 58,783,503 58,691,164 ( 99.84 %) 0 99.84 %

Shareholders

NameEquities%Valuation
Lyxor Asset Management SAS
0.0366 %
21,498 0.0366 % - $
Madison Park Capital Advisors LLC
0.0170 %
10,000 0.0170 % - $

Company contact information

Genocea Biosciences, Inc.

Cambridge Discovery Park 100 Acorn Park Drive

02140, Cambridge

+617 876 8191

http://www.genocea.com
address Genocea Biosciences, Inc.(GNCAQ)